Furthermore, the protein levels of PRMT1 and H4R3me2a, its histone methylation marker, were dramatically increased in CML CD34+ cells compared with normal CD34+ cells as detected by Western blotting analysis (Figure 1C). The gene discussed is PRMT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.